Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Wong BCY et al. – The standard 7–day clarithromycin–containing triple therapy is still valid as the most effective empirical first–line eradication therapy for H. pylori infection in Hong Kong, as prevalence of primary resistance of H. pylori to amoxycillin and clarithromycin remains low. Patients who failed their empirical first–line eradication therapy should undergo H. pylori susceptibility testing to guide further treatment.
Related Articles
Peptic ulcer disease and helicobacter pylori infection at kano, nigeria
The Internet Journal of Gastroenterology, 11/11/09
Relevance Score: 69%
Reactive Nitrogen Species Mediate DNA Damage in Helicobacter pylori-Infected Gastric Mucosa
Helicobacter, 11/09/09
Relevance Score: 68%
Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country
Acta Pediatrica, 10/28/09
Relevance Score: 68%
In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability
Journal of Pharmacy and Pharmacology, 10/14/09
Relevance Score: 68%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Article Search
Sponsor


See Latest Articles


